Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation
about
Anti-VEGF Cancer Therapy in Nephrology PracticeKidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center.Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.Unlikely association of nephrectomy post-mRCC with anti-VEGF-induced renal TMA.
P2860
Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Thrombotic microangiopathy ass ...... with factor V Leiden mutation
@ast
Thrombotic microangiopathy ass ...... with factor V Leiden mutation
@en
type
label
Thrombotic microangiopathy ass ...... with factor V Leiden mutation
@ast
Thrombotic microangiopathy ass ...... with factor V Leiden mutation
@en
prefLabel
Thrombotic microangiopathy ass ...... with factor V Leiden mutation
@ast
Thrombotic microangiopathy ass ...... with factor V Leiden mutation
@en
P2093
P2860
P356
P1433
P1476
Thrombotic microangiopathy ass ...... with factor V Leiden mutation
@en
P2093
David J Leehey
Joseph I Clark
Kevin Barton
Maria M Picken
Randeep S Bajwa
Seth A Levey
P2860
P304
P356
10.1093/NDTPLUS/SFN013
P577
2008-03-11T00:00:00Z